|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.900 USD | +2.37% |
|
-3.50% | +3.76% |
| 06-22 | Evolus, Inc.(NasdaqGM:EOLS) added to S&P Pharmaceuticals Select Industry Index | CI |
| 05-11 | Evolus, Inc. Launches Estyme Injectable Hyaluronic Acid Gels Collection in Europe | CI |
| Market Cap | 454M 397M 365M 340M 645M 43.27B 655M 4.38B 1.7B 21.27B 1.71B 1.67B 73.28B | P/E 2026 * |
-13.9x | P/E 2027 * | -47x |
|---|---|---|---|---|---|
| Enterprise Value | 581M 508M 467M 435M 826M 55.36B 838M 5.61B 2.18B 27.21B 2.18B 2.14B 93.77B | EV / Sales 2026 * |
1.76x | EV / Sales 2027 * | 1.51x |
| Free-Float |
83.36% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Evolus, Inc.
| 1 day | +2.37% | ||
| 1 week | -3.50% | ||
| Current month | -0.58% | ||
| 1 month | +11.83% | ||
| 3 months | +71.22% | ||
| 6 months | +2.68% | ||
| Current year | +3.76% |
| 1 week | 6.7 |  | 7.18 |
| 1 month | 6.05 | | 7.32 |
| Current year | 3.86 | | 7.32 |
| 1 year | 3.86 | | 10.2 |
| 3 years | 3.86 | | 17.82 |
| 5 years | 3.86 | | 17.82 |
| 10 years | 2.85 | | 39.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
David Moatazedi
CEO | Chief Executive Officer | 48 | 05/05/2018 |
Tatjana Mitchell
DFI | Director of Finance/CFO | 48 | 07/09/2025 |
Jon Yerbury
COO | Chief Operating Officer | - | 31/08/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Vikram Malik
CHM | Chairman | 63 | 31/12/2017 |
David Gill
BRD | Director/Board Member | 71 | 11/02/2018 |
David Moatazedi
BRD | Director/Board Member | 48 | 05/05/2018 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 03-19 | Sell | Chief Technology Officer | 3,119 | 0.0048% | ||
| 03-19 | Sell | Chief Executive Officer | 13,669 | 0.0211% | ||
| 03-15 | Fiscal year | Chief Technology Officer | 47,604 | 0.0736% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.37% | -3.50% | -25.08% | -5.09% | 454M | |
| +3.45% | +7.65% | +55.77% | +158.84% | 1,082B | |
| -1.16% | +7.42% | +69.09% | +58.92% | 633B | |
| -0.77% | +7.37% | +36.87% | +93.77% | 461B | |
| -0.35% | +1.85% | +31.30% | +24.86% | 339B | |
| -0.56% | +1.17% | +41.96% | +39.64% | 301B | |
| -0.08% | +1.49% | +32.40% | +44.75% | 292B | |
| -1.54% | +2.58% | -25.52% | -39.75% | 225B | |
| +3.55% | +6.05% | +26.04% | +68.52% | 202B | |
| +0.40% | +6.00% | +17.72% | +70.33% | 163B | |
| Average | +1.58% | +1.75% | +26.05% | +51.48% | 370.02B | |
| Weighted average by Cap. | +1.37% | +1.96% | +42.23% | +81.70% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 330M 289M 265M 247M 469M 31.46B 476M 3.19B 1.24B 15.47B 1.24B 1.21B 53.3B | 388M 339M 311M 290M 551M 36.91B 559M 3.74B 1.45B 18.14B 1.46B 1.42B 62.52B |
| Net income | -33.31M -29.12M -26.76M -24.94M -47.31M -3.17B -48.03M -321M -125M -1.56B -125M -122M -5.37B | -10.56M -9.23M -8.49M -7.91M -15M -1.01B -15.23M -102M -39.6M -494M -39.64M -38.79M -1.7B |
| Net Debt | 127M 111M 102M 95.1M 180M 12.09B 183M 1.22B 476M 5.94B 477M 466M 20.48B | 132M 115M 106M 98.85M 187M 12.57B 190M 1.27B 495M 6.18B 495M 485M 21.29B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/07/26 | US$6.900 | +2.37% | 534,868 |
| 01/07/26 | US$6.740 | -2.88% | 567,581 |
| 30/06/26 | US$6.940 | -2.66% | 596,307 |
| 29/06/26 | US$7.130 | 0.00% | 670,035 |
| 26/06/26 | US$7.130 | -0.28% | 2,075,327 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- EOLS Stock
Select your edition
All financial news and data tailored to specific country editions
